New Delhi, India

Gowri Shankar

This inventor holds 1 USPTO granted patent. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gowri Shankar. Retrieved from https://idiyas.com/inventor/gowri-shankar-2pj1kgaf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gowri Shankar: Innovator in HMG CoA-Reductase Inhibitors

Introduction

Gowri Shankar is a prominent inventor based in New Delhi, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of HMG CoA-reductase inhibitors. Her innovative work has the potential to impact the treatment of various health conditions.

Latest Patents

Gowri Shankar holds 1 patent related to her invention of HMG CoA-reductase inhibitors. This patent focuses on specific hydroxyl and protected hydroxyl derivatives of compounds that are known to be useful in this area. The invention provides hydroxyl and protected hydroxyl compounds of Formula I and their corresponding lactones, showcasing her expertise in medicinal chemistry.

Career Highlights

Gowri Shankar is currently employed at Ranbaxy Laboratories, Inc., where she continues to advance her research and development efforts. Her work at this esteemed pharmaceutical company has allowed her to collaborate with other talented professionals in the industry.

Collaborations

Some of her notable coworkers include Bhargav R Panyda and Ramnik Sharma. Their collective efforts contribute to the innovative environment at Ranbaxy Laboratories, Inc.

Conclusion

Gowri Shankar is a remarkable inventor whose work in HMG CoA-reductase inhibitors exemplifies her dedication to advancing pharmaceutical science. Her contributions are poised to make a lasting impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…